Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can an antibiotic shorten chest tube time for cancer patients with lung fluid?

NCT ID NCT03465774

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 30 times

Summary

This study looks at two ways to treat malignant pleural effusion, a buildup of fluid in the lungs caused by cancer. One uses a small tube (indwelling pleural catheter) to drain fluid; the other adds the antibiotic doxycycline to help seal the lung. Researchers want to see if adding doxycycline lets patients have the tube removed sooner. About 208 adults with cancer-related fluid buildup will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLEURAL NEOPLASM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

doxycycline

What this could lead to

If adding doxycycline works, patients may need the chest tube for a shorter time, reducing discomfort and infection risk.

What could go wrong

This is an early observational study, not a large randomized trial. Doxycycline may not speed up recovery and could cause side effects like pain or infection.

Conditions

The condition(s) this trial relates to.

pleural neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.